Cargando…

Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections

BACKGROUND: The purpose of the current study was to analyze risk factors, clinical features, and treatment outcomes in patients with endogenous fungal endophthalmitis with yeast and mold infections. For this retrospective consecutive case series, microbiologic and clinical records were reviewed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sridhar, Jayanth, Flynn, Harry W, Kuriyan, Ajay E, Miller, Darlene, Albini, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848556/
https://www.ncbi.nlm.nih.gov/pubmed/24053550
http://dx.doi.org/10.1186/1869-5760-3-60
_version_ 1782293778028036096
author Sridhar, Jayanth
Flynn, Harry W
Kuriyan, Ajay E
Miller, Darlene
Albini, Thomas
author_facet Sridhar, Jayanth
Flynn, Harry W
Kuriyan, Ajay E
Miller, Darlene
Albini, Thomas
author_sort Sridhar, Jayanth
collection PubMed
description BACKGROUND: The purpose of the current study was to analyze risk factors, clinical features, and treatment outcomes in patients with endogenous fungal endophthalmitis with yeast and mold infections. For this retrospective consecutive case series, microbiologic and clinical records were reviewed to identify all patients with intraocular culture-proven endogenous fungal endophthalmitis treated at a single institution between January 1, 1990 and December 31, 2011. RESULTS: Sixty-seven eyes of 53 patients were identified; 51 eyes of 39 patients had positive cultures for yeast and 16 eyes of 14 patients had positive cultures for molds. Patients with molds as a causative organism had significantly shorter duration of symptoms prior to diagnosis (molds 3.8 days, yeast 21.0 days, p = 0.002), were more likely to be receiving iatrogenic immunosuppression (molds 57.1%, yeast 7.7%, p = 0.001), have a history of whole-organ transplantation (molds 35.7%, yeast 2.6%, p = 0.001), and were more likely to have hypopyon at the time of diagnosis (molds 37.5%, yeast 6.0%, p = 0.001). Patients with endogenous endophthalmitis caused by molds had significantly worse visual acuity at the time of diagnosis (logMAR visual acuity molds 1.80, yeast 1.15, p = 0.008) and at final visit (logMAR visual acuity molds 1.97, yeast 1.05, p = 0.005) compared to those patients with yeast as a causative organism. There was no significant difference in the rate of retinal detachment between the two groups (mold 12.5%, yeast 30.6%, p = 0.201). Patients with cultures positive for mold were significantly more likely to undergo enucleation (molds 25.0%, yeast 0%, p < 0.001). CONCLUSIONS: Systemic risk factors for patients with endogenous fungal endophthalmitis caused by molds were iatrogenic immunosuppression and a history of whole-organ transplantation. Shorter duration of symptoms before diagnosis and higher rates of hypopyon occurred in mold cases. While endogenous fungal endophthalmitis is generally associated with poor visual acuity outcomes, infection with mold species was associated with worse visual acuity on presentation and on final follow-up than infection with yeast species. Enucleation rates were much higher in mold cases.
format Online
Article
Text
id pubmed-3848556
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-38485562013-12-06 Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections Sridhar, Jayanth Flynn, Harry W Kuriyan, Ajay E Miller, Darlene Albini, Thomas J Ophthalmic Inflamm Infect Original Research BACKGROUND: The purpose of the current study was to analyze risk factors, clinical features, and treatment outcomes in patients with endogenous fungal endophthalmitis with yeast and mold infections. For this retrospective consecutive case series, microbiologic and clinical records were reviewed to identify all patients with intraocular culture-proven endogenous fungal endophthalmitis treated at a single institution between January 1, 1990 and December 31, 2011. RESULTS: Sixty-seven eyes of 53 patients were identified; 51 eyes of 39 patients had positive cultures for yeast and 16 eyes of 14 patients had positive cultures for molds. Patients with molds as a causative organism had significantly shorter duration of symptoms prior to diagnosis (molds 3.8 days, yeast 21.0 days, p = 0.002), were more likely to be receiving iatrogenic immunosuppression (molds 57.1%, yeast 7.7%, p = 0.001), have a history of whole-organ transplantation (molds 35.7%, yeast 2.6%, p = 0.001), and were more likely to have hypopyon at the time of diagnosis (molds 37.5%, yeast 6.0%, p = 0.001). Patients with endogenous endophthalmitis caused by molds had significantly worse visual acuity at the time of diagnosis (logMAR visual acuity molds 1.80, yeast 1.15, p = 0.008) and at final visit (logMAR visual acuity molds 1.97, yeast 1.05, p = 0.005) compared to those patients with yeast as a causative organism. There was no significant difference in the rate of retinal detachment between the two groups (mold 12.5%, yeast 30.6%, p = 0.201). Patients with cultures positive for mold were significantly more likely to undergo enucleation (molds 25.0%, yeast 0%, p < 0.001). CONCLUSIONS: Systemic risk factors for patients with endogenous fungal endophthalmitis caused by molds were iatrogenic immunosuppression and a history of whole-organ transplantation. Shorter duration of symptoms before diagnosis and higher rates of hypopyon occurred in mold cases. While endogenous fungal endophthalmitis is generally associated with poor visual acuity outcomes, infection with mold species was associated with worse visual acuity on presentation and on final follow-up than infection with yeast species. Enucleation rates were much higher in mold cases. Springer 2013-09-20 /pmc/articles/PMC3848556/ /pubmed/24053550 http://dx.doi.org/10.1186/1869-5760-3-60 Text en Copyright © 2013 Sridhar et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Sridhar, Jayanth
Flynn, Harry W
Kuriyan, Ajay E
Miller, Darlene
Albini, Thomas
Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title_full Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title_fullStr Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title_full_unstemmed Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title_short Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
title_sort endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848556/
https://www.ncbi.nlm.nih.gov/pubmed/24053550
http://dx.doi.org/10.1186/1869-5760-3-60
work_keys_str_mv AT sridharjayanth endogenousfungalendophthalmitisriskfactorsclinicalfeaturesandtreatmentoutcomesinmoldandyeastinfections
AT flynnharryw endogenousfungalendophthalmitisriskfactorsclinicalfeaturesandtreatmentoutcomesinmoldandyeastinfections
AT kuriyanajaye endogenousfungalendophthalmitisriskfactorsclinicalfeaturesandtreatmentoutcomesinmoldandyeastinfections
AT millerdarlene endogenousfungalendophthalmitisriskfactorsclinicalfeaturesandtreatmentoutcomesinmoldandyeastinfections
AT albinithomas endogenousfungalendophthalmitisriskfactorsclinicalfeaturesandtreatmentoutcomesinmoldandyeastinfections